Latest / Health and life sciences

DealHealthScienceUK US SwitzerlandConfirmed

Isomorphic Labs signs AI drug-design deals with Eli Lilly and Novartis worth nearly $3bn

See how this story connects

Isomorphic Labs announced AI drug-discovery research collaborations with Eli Lilly and Novartis on 7 January 2024. Lilly paid $45m upfront and Novartis $37.5m, and the two deals together could pay Isomorphic nearly $3bn in upfront and milestone payments, excluding royalties.

Why it matters

Two large drugmakers put $82.5m upfront into AI-led drug design at one company, with nearly $3bn more possible if programmes reach their milestones.

When
7 Jan 2024
ID
WTA-N-2024-0001
Where
United Kingdom, United States, Switzerland
Who
Isomorphic Labs, Eli Lilly, Novartis

Summary by wheresthe.ai, from Isomorphic Labs. Checked against the source on 9 Oct 2026.

Source copy: download the page as saved on 18 Oct 2026 (PDF). Also held by the Internet Archive.

Next stop on this Storyline: What happened nextIsomorphic Labs raises $2.1bn for its AI drug-design engine

Cite this story

WTA-N-2024-0001: “Isomorphic Labs signs AI drug-design deals with Eli Lilly and Novartis worth nearly $3bn.” wheresthe.ai, 7 Jan 2024. https://wheresthe.ai/d/gb-isomorphic-labs-lilly-novartis-deals-2024-01/ (source: Isomorphic Labs).

Spotted an error? Email [email protected].